Literature DB >> 7556625

Expression and disulfide-bond connectivity of the second ligand-binding repeat of the human LDL receptor.

S Bieri1, J T Djordjevic, N Jamshidi, R Smith, P A Kroon.   

Abstract

The human LDL receptor (LDLR) has a binding domain which consists of seven contiguous ligand-binding (LB) repeats, each approximately 40 amino acids long with three disulfide bonds. The second LB repeat, which is required for full binding of LDL, has been expressed, purified and folded to yield a single, fully oxidized isomer. By selective reduction and alkylation, we have shown that the cysteine residues have a I-III, II-V, IV-VI connectivity, matching that recently determined for the amino-terminal repeat. We suggest that the first two LB repeats of the LDLR, with their unique disulfide-bonding pattern, serve as a structural paradigm for other LB repeats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556625     DOI: 10.1016/0014-5793(95)00939-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  NMR structure of a concatemer of the first and second ligand-binding modules of the human low-density lipoprotein receptor.

Authors:  N D Kurniawan; A R Atkins; S Bieri; C J Brown; I M Brereton; P A Kroon; R Smith
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

2.  Calcium as a crucial cofactor for low density lipoprotein receptor folding in the endoplasmic reticulum.

Authors:  Florentina Pena; Annemieke Jansens; Guus van Zadelhoff; Ineke Braakman
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

3.  The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor.

Authors:  Tadao Iwasaki; Sadao Takahashi; Mitsuaki Ishihara; Masafumi Takahashi; Uichi Ikeda; Kazuyuki Shimada; Takahiro Fujino; Tokuo T Yamamoto; Hiroaki Hattori; Mitsuru Emi
Journal:  J Hum Genet       Date:  2004-10-01       Impact factor: 3.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.